Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 7 February 2017 - 10 April 2017
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 017
- Report date:
- 2017
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Version / remarks:
- 21 July 1997
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: ''Regulation on Test Methods for Chemical Substances”, Notification No. 2016-27, National Institute of Environmental Research, Republic of Korea
- Version / remarks:
- 19 December 2016
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 1,3,5-tris(5-isocyanatopentyl)-1,3,5-triazinane-2,4,6-trione
- Cas Number:
- 119934-71-3
- Molecular formula:
- C21 H30 N6 O6
- IUPAC Name:
- 1,3,5-tris(5-isocyanatopentyl)-1,3,5-triazinane-2,4,6-trione
- Reference substance name:
- 2-methylpropyl N-(5-isocyanatopentyl)-N-(5-isocyanatopentylcarbamoyl)carbamate
- Molecular formula:
- C18 H30 N4 O5
- IUPAC Name:
- 2-methylpropyl N-(5-isocyanatopentyl)-N-(5-isocyanatopentylcarbamoyl)carbamate
- Test material form:
- liquid: viscous
- Details on test material:
- Appearance: colourless or light yellow viscous liquid
Storage conditions: at room temperature, container tightly closed, flushed with nitrogen.
Constituent 1
Constituent 2
- Specific details on test material used for the study:
- - No correction for purity was made
Method
- Target gene:
- Salmonella typhimurium: histidine gene
Escherichia coli: tryptophan gene
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9-mix derived from male rats induced with phenobarbital and 5,6-benzoflavone
- Test concentrations with justification for top dose:
- Dose range finding study (all strains): 4.88, 19.5, 78.1, 313, 1250 and 5000 μg/plate (top dose was selected according to the test guideline).
First and second (main) experiment (without S9): TA98 and TA1535: 9.77, 19.5, 39.1, 78.1, 156 and 313 μg/plate; TA100 and TA1537: 2.44, 4.88, 9.77, 19.5, 39.1 and 78.1 μg/plate; WP2uvrA: 39.1, 78.1, 156, 313, 625 and 1250 μg/plate
First and second (main) experiment (with S9): TA100 and TA1537: 9.77, 19.5, 39.1, 78.1, 156 and 313 μg/plate; TA98 and TA1535: 39.1, 78.1, 156, 313, 625 and 1250 μg/plate; WP2uvrA: 156, 313, 625, 1250, 2500 and 5000 μg/plate
(top doses were selected at the lowest dose level at which growth inhibition was confirmed) - Vehicle / solvent:
- - Vehicle used: dimethyl sulfoxide
- Justification for choice of vehicle: because the test substance is unstable in water, a preliminiary solubility test was performed. The test substance was dissolved in DMSO. The vehicle is selected according to OECD guideline 471.
Controls
- Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 4-nitroquinoline-N-oxide
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- benzo(a)pyrene
- other: 2-aminoanthracene
- Remarks:
- See table 1 in ''Any other information on materials and methods incl. tables''
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in glucose agar
- Cell density at seeding: 10^9 cells/mL
DURATION
- Preincubation period: no
- Exposure duration: 48 hours
NUMBER OF REPLICATIONS: 3 plates/dose
DETERMINATION OF CYTOTOXICITY
- Method: colonies were counted by a colony counter (ProtoCOL3, Syniosis, UK). To confirm the presence or absence of growth inhibition, the background lawn was observed using a stereoscopic microscope (45-fold magnification, SZ61, Olympus, Japan).
OTHER:
- Evaluation of microbial contamination: the presence or absence of colonies formed by microbial contamination in the plates was evaluated by placing 100 μL of the high dose formulation, 500 μL of 0.1 mol/L sodium phosphate buffer (pH 7.4) and 500 μL of S9 mix in tubes and incubating these in a shaking water bath (37°C, 90 rpm) for 20 minutes, followed by a 48 hour incubation period.
ACCEPTABILITY CRITERIA
- The mean number of revertant colonies for the negative and positive controls should be within the range of the historical control data or the mean number of revertant colonies in the positive control groups should be increased at least twice as compared to the negative control group.
- No plate should show any evidence of contamination. - Evaluation criteria:
- The results of the study were considered to be positive when the number of revertant colonies in any strain at one or more doses was increased at least two times when compared to the negative control group. There should be dose dependency or reproducibility as dose increases.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Key result
- Species / strain:
- E. coli WP2 uvr A
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation (dose range finding study): at 5000 μg/plate (without S9) and from 1250 μg/plate (with S9)
- Precipitation (main studies): only with S9: at dose levels > 625 μg/plate for TA98, TA1535 and WP2uvrA
GROWTH INHIBITION:
Main studies (without S9): at 313 μg/plate for TA98; above 39.1 μg/plate for TA100 and TA1537; above 156 μg/plate for TA1535; at 1250 μg/plate for WP2uvrA.
Main studies (with S9): above 625 μg/plate for TA98 and TA1535; at 313 μg/plate for TA100 and TA1537 and above 2500 μg/plate for WP2uvrA.
HISTORICAL DATA: the mean number of revertant colonies for the negative and positive control groups was within the range of the historical control data (Table 5) and the number of revertant colonies of the positive control groups was markedly increased at least twice when compared to the negative control group. Also, there was no contamination.
Any other information on results incl. tables
Table 2 Historical negative control values of revertant colonies
|
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
|||||
S9-mix |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
Range |
4.7-15.5 |
3.9-14.9 |
3.3-11.7 |
8.4-21.4 |
9.6-26.1 |
14.3-37.6 |
60.5-110.9 |
64.9-125.1 |
73.9-167.6 |
87.3-198.2 |
Mean |
10.1 |
9.4 |
7.5 |
14.9 |
17.9 |
25.9 |
85.7 |
95.0 |
120.8 |
142.7 |
SD |
2.1 |
1.9 |
1.4 |
2.6 |
3.0 |
4.0 |
10.2 |
12.0 |
17.3 |
18.7 |
n |
125 |
125 |
125 |
125 |
125 |
125 |
125 |
125 |
125 |
125 |
Table 3 Historical positive control values of revertant colonies
|
TA1535 |
TA1537 |
TA98 |
TA100 |
WP2uvrA |
|||||
S9-mix |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
- |
+ |
Range |
353.6-582.6 |
67.0-165.7 |
237.0-638.9 |
77.9-189.5 |
392.3-762.9 |
84.6-258.5 |
440.0-711.4 |
149.8-314.3 |
209.1-1163.3 |
304.5-610.5 |
Mean |
468.1 |
116.3 |
437.9 |
133.7 |
577.6 |
171.5 |
575.7 |
232.1 |
686.2 |
457.5 |
SD |
47.4 |
19.2 |
128.5 |
18.6 |
87.4 |
32.3 |
55.0 |
32.1 |
160.7 |
59.3 |
n |
119 |
125 |
119 |
52 |
119 |
52 |
119 |
52 |
23 |
125 |
Applicant's summary and conclusion
- Conclusions:
- Based on the results of an Ames test, performed according to OECD guideline 471, STABiO D-376N was concluded not to be mutagenic.
- Executive summary:
An Ames test was performed, according to OECD guideline 471 and GLP principles, to assess the mutagenic potential of STABiO D-376N. Four Salmonella typhimurium strains (TA98, TA100, TA1535 and TA1537) and one Escherichia coli strain
(WP2uvrA) were used in the presence and absence of a metabolic activation system (S9). In the dose range finding test, the test substance was tested up to a dose level of 5000 μg/plate. In the two main tests, dose levels were tested up to the lowest dose level where precipitation occurred in the range finding test. The mean number of revertant colonies for the negative and positive controls were within the historical data range. In the positive control group, the mean number of revertant colonies was markedly increased more than twice when compared to that of the negative control group. In the main tests, the mean number of revertant colonies was less than twice when compared to the negative control group at all dose levels of the test substance in the presence and absence of metabolic activation. Based on the results of this study, STABiO is considered not to be mutagenic in the Salmonella typhimurium reverse assay and the Escherichia coli reverse assay.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.